MGS Leverages Vertical Integration to Quickly Scale Critical Part Production

Offering deep competencies in complex tooling, molding, and equipment solutions, contract manufacturing partner MGS is playing a critical role in supporting significant increases in demand for test kits and ventilators that are essential to reopening the U.S. economy.

Moving quickly and efficiently to launch production, the company’s vertical integration across mold building, cleanroom molding, multi-shot equipment, robotics and more has uniquely positioned it to successfully scale up production of critical plastic components.

Helping America meet the first, critical objective of supplying millions of COVID-19 tests, the company is playing an integral role in the manufacturing of plastic consumable parts, scaling initial production nearly thirty-fold to rapidly supply components. Through its expertise in high-cavitation mold design and builds for challenging, tight-tolerance parts, as well as in multi-shot injection molding, MGS is serving a critical role in meeting nationwide demand for effective testing.

MGS also quickly pivoted to supply critical components to support production of approximately 30,000 ventilators in partnership with Ventec and GM. Scaling production to meet the rapid increase in demand, MGS was tasked with transferring a machined plastic valve – eight of which are needed for each ventilator – to an injection molding process that would produce parts in seconds, rather than the minutes needed for the original process.

With decades of experience in mold building for companies in healthcare and pharmaceutical industries, MGS engineered, built, and launched a tool in only eight days, demolishing what would traditionally be an eight- to ten-week timeline.